Illumina, Inc. (VIE:ILMN)

Austria flag Austria · Delayed Price · Currency is EUR
109.50
-1.16 (-1.05%)
Last updated: Dec 4, 2025, 5:32 PM CET
-18.72%
Market Cap 16.78B
Revenue (ttm) 3.67B
Net Income (ttm) 601.21M
Shares Out n/a
EPS (ttm) 3.81
PE Ratio 27.90
Forward PE 25.76
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 109.78
Previous Close 110.66
Day's Range 109.38 - 109.78
52-Week Range 62.25 - 143.80
Beta n/a
RSI 62.58
Earnings Date Feb 6, 2026

About Illumina

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole... [Read more]

Industry Laboratory Analytical Instruments
Founded 1998
Employees 9,030
Stock Exchange Vienna Stock Exchange
Ticker Symbol ILMN
Full Company Profile

Financial Performance

In 2024, Illumina's revenue was $4.37 billion, a decrease of -2.93% compared to the previous year's $4.50 billion. Losses were -$1.22 billion, 5.34% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.